Differentiating genomics companies: as the value of raw sequence data diminishes, genomics comapnies are evolving new competencies as providers of information, therapeutic products, or novel technology

Article Abstract:

Paris, France-based Genset, Rockville, MD-based Celera Genomics and Gaithersburg, MD-based Gene Logic have enjoyed the escalation of their share values as have other genome sequencing companies.

France, Securities issued, listed, Maryland, Life Sciences, Celera Genomics Group, Genset S.A., Gene Logic Inc.

---

Applications of display technology in protein analysis

Article Abstract:

Overview of biological display technology, and its uses in developing and expanding genetic libraries, and in gene mapping.

---

Nuclear security breached. DNA chemistry may provide a solution to the deceptively difficult problem of enhancing DNA nuclear transport in nonviral vectors

Article Abstract:

Rebuffat et al have tagged plasmid DNA with steroid, and dexamethasone. This research is promising for gene therapy.

Similar abstracts:

• Abstracts: Banking's identity crisis: the need for branding. Harnessing customer information. No guarantees in database marketing
• Abstracts: Muscling in on bone formation. Beyond comparison - antibiotics from genome data? Microbial genomics is producing a plethora of candidate targets for developing new classes of antimicrobial agents
• Abstracts: Organizational positioning in retail financial services. A cross-cultural perspective on the role of branding in financial services: the small business market
• Abstracts: Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells
• Abstracts: Characterizing biological products and assessing comparability following manufacturing changes. Vitreous cryopreservation maintains the function of vascular grafts

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.